ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

An advanced AI tool can detect tiny brain lesions that cause severe epilepsy in children, allowing faster diagnosis, more ...

STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

An artificial intelligence tool that can detect tiny, hard-to-spot brain malformations in children with epilepsy could help ...

Melbourne researchers test a new AI tool that detects tiny lesions in children with epilepsy, leading to surgeries that leave ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

NEW HAVEN, Conn. (KABC) -- Every state has different requirements when it comes to driving with epilepsy. Here in California, patients must be seizure-free for a specific period of time and submit a ...

An 11-year-old Greek Australian boy, John Kounadis, has been cured of epilepsy after AI technology at Melbourne’s Royal ...

The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...

NeuLine Health (844-212-5321) launches its mobile electroencephalogram (EEG) testing program for residents in Atlanta. McKinney, United States - December 1, 2023 — The new ambulatory EEG bridges the ...

The Patient Access Program helps to ensure more equitable care across pediatric epilepsy populations. Exome testing is recommended as a first-line test for patients with unexplained epilepsy by the ...